# rTSST-1 Variant Vaccine Phase 1 First-in-man Trail

> **NCT02340338** · PHASE1 · COMPLETED · sponsor: **Biomedizinische Forschungs gmbH** · enrollment: 46 (actual)

## Conditions studied

- Toxic Shock Syndrome
- Vaccination; Sepsis

## Interventions

- **BIOLOGICAL:** rTSST-1 Variant Candidate Vaccine

## Key facts

- **NCT ID:** NCT02340338
- **Lead sponsor:** Biomedizinische Forschungs gmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-06
- **Final completion:** 2015-07
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2017-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02340338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02340338, "rTSST-1 Variant Vaccine Phase 1 First-in-man Trail". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02340338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*